Karine Mardon
Queensland NIF Node Facility Fellow
Dr Karine Mardon obtained her PhD in radiopharmacology from University Paris XII in 1994; she then moved to Australia to pursue postdoctoral studies at ANSTO in the Radiopharmaceutical Division and worked there for 5 years in the development and characterisation of radiopharmaceuticals for SPECT and PET. She has extensive experience with in vitro and in vivo preclinical research, particularly in the evaluation of drugs developed for the study of movement disorders as well as in the evaluation of radiolabelled peripheral benzodiazepine receptor ligands as markers of neurodegeneration and tumour occurrence. She moved to Brisbane in 2000 and joined the University of Queensland where she developed further experience working in the field of preclinical drug development in the ADME division of TetraQ. She joined the Centre for Advanced Imaging in October 2010 as NIF Facility Fellow for preclinical PET/CT.
Related News
Australian ovarian cancer breakthrough enters human trials
The Australian National Imaging Facility and Therapeutic Innovation Australia have supported development of a promising new ovarian cancer drug from early-stage development, through preclinical studie
07 November 2025
Precision medicine breaks postcode and time barriers for people living with epilepsy
The Australian Epilepsy Project has seven MRI scanning sites across five states as part of a national network to provide epilepsy patients with access to advanced diagnostic testing that was otherwise
15 October 2025
National award for Neurodesk’s pioneering open-science neuroimaging platform
Neurodesk’s innovative ability to help researchers process and analyse massive neuroimaging datasets was recognised late last month at the 2025 National iAwards, presented in Adelaide. Neurodesk is
07 October 2025
9 News: Recent epilepsy breakthroughs use imaging data captured on NIF instruments
Reported by 9News, Clinical Director of The Florey Professor Graeme Jackson was interviewed about the technology developed at the Australian Epilepsy project.
26 June 2025
Related Capabilities
Related Publications
Toward the future of scientific publishing through reproducible research artefacts enabled by Neurodesk
Michèle Masson‑Trottier, Thuy T. Dao, Aswin Narayanan, Steffen Bollmann
Read Publication
T₁‑weighted fMRI in mouse visual cortex using an iron oxide nanoparticle contrast agent and UTE imaging at 9.4 T
Naman Jain, Saskia Bollmann, Kai‑Hsiang Chuang, Jonathan R. Polimeni, Markus Barth
Read Publication
The histone methyltransferase SETD2 regulates adult brain structure, connectivity and neurogenesis
Cooper Atterton, Hallie Naumann, Benjamin Mitchell, Bee Meibusch, Laura Currey, Nyoman D. Kurniawan, Stefan Thor, Michael Piper
Read Publication
Towards fair decentralized benchmarking of healthcare AI algorithms with the Federated Tumor Segmentation (FeTS) challenge
Maximilian Zenk, Ujjwal Baid, Sarthak Pati, Akis Linardos, Brandon Edwards, Micah Sheller, Patrick Foley, Alejandro Aristizabal, David Zimmerer, Alexey Gruzdev, Jason Martin, Russell T. Shinohara, Annika Reinke, Fabian Isensee, Santhosh Parampottupadam, Kaushal Parekh, Ralf Floca, Hasan Kassem, Bhakti Baheti, Siddhesh Thakur, Verena Chung, Kaisar Kushibar, Karim Lekadir, Meirui Jiang, Youtan Yin, Hongzheng Yang, Quande Liu, et al.
Read Publication